Eterna Therapeutics Stock Forecast - Accumulation Distribution
| ERNA Stock | USD 0.29 0.03 9.38% |
Eterna Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Eterna Therapeutics stock prices and determine the direction of Eterna Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Eterna Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Eterna |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 47210.67 | 36363.62 |
| Check Eterna Therapeutics Volatility | Backtest Eterna Therapeutics | Information Ratio |
Eterna Therapeutics Trading Date Momentum
| On December 13 2024 Eterna Therapeutics was traded for 0.29 at the closing time. The top price for the day was 0.32 and the lowest listed price was 0.28 . The trading volume for the day was 290.9 K. The trading history from December 13, 2024 did not affect price variability. The overall trading delta against the current closing price is 3.45% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Eterna Therapeutics to competition |
Other Forecasting Options for Eterna Therapeutics
For every potential investor in Eterna, whether a beginner or expert, Eterna Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eterna Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eterna. Basic forecasting techniques help filter out the noise by identifying Eterna Therapeutics' price trends.View Eterna Therapeutics Related Equities
| Risk & Return | Correlation |
Eterna Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Eterna Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Eterna Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eterna Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Eterna Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eterna Therapeutics shares will generate the highest return on investment. By undertsting and applying Eterna Therapeutics stock market strength indicators, traders can identify Eterna Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 36363.62 | |||
| Daily Balance Of Power | (0.75) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 0.3 | |||
| Day Typical Price | 0.3 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.03) |
Eterna Therapeutics Risk Indicators
The analysis of Eterna Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eterna Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eterna stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.47 | |||
| Standard Deviation | 7.56 | |||
| Variance | 57.12 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Eterna Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eterna Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eterna Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eterna Therapeutics Stock:Check out Historical Fundamental Analysis of Eterna Therapeutics to cross-verify your projections. For information on how to trade Eterna Stock refer to our How to Trade Eterna Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eterna Therapeutics. If investors know Eterna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eterna Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.31) | Revenue Per Share 0.03 | Return On Assets (0.29) | Return On Equity (11.54) |
The market value of Eterna Therapeutics is measured differently than its book value, which is the value of Eterna that is recorded on the company's balance sheet. Investors also form their own opinion of Eterna Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Eterna Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eterna Therapeutics' market value can be influenced by many factors that don't directly affect Eterna Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eterna Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eterna Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eterna Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.